PHARMACYTE BIOTECH, INC. Other Accrued Liabilities, Current
PHARMACYTE BIOTECH, INC. (PMCB) had Other Accrued Liabilities, Current of $287.31 thousand as of 2023-07-31, per its 10-Q filed 2023-09-18.
Discontinued › Notes › Payables and Accruals › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:OtherAccruedLiabilitiesCurrent · last filed 2023-09-18
- 2023-07-31: Other Accrued Liabilities, Current $287.31K.
- 2023-04-30: Other Accrued Liabilities, Current $287.31K.
- 2023-01-31: Other Accrued Liabilities, Current $287.31K.
- 2022-10-31: Other Accrued Liabilities, Current $377.15K.
| Period end | Other Accrued Liabilities, Current |
|---|---|
| 2023-07-31 | $287.31K 10-Q · filed 2023-09-18 |
| 2023-04-30 | $287.31K 10-Q · filed 2023-09-18 |
| 2023-01-31 | $287.31K 10-Q · filed 2023-03-16 |
| 2022-10-31 | $377.15K 10-Q · filed 2022-12-14 |
| 2022-07-31 | $377.15K 10-Q · filed 2022-09-14 |
| 2022-04-30 | $377.15K 10-K · filed 2023-07-31 |
| 2022-01-31 | $467.00K 10-Q · filed 2022-03-15 |
| 2021-04-30 | $0.00 10-K · filed 2022-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |